Physician profile
Alejandro Arango
NPI 1700267408
$5,572.52
in general payments reported to CMS, 2019-2025
14 companies · $425 in 2025
The $425 reported for 2025 was more than what 75% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,154 · 2020: $327 · 2021: $420 · 2022: $323 · 2023: $152 · 2024: $2,772 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,112 · Food and Beverage: $1,087 · Entertainment: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,111.59 |
| Food and Beverage | $1,086.52 |
| Entertainment | $150.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,605.02 | 2019-2022 | |
| Zimvie INC. | $1,303.29 | 2024-2025 | |
| Techfit Digital Surgery INC | $1,011.46 | 2024 | |
| Straumann USA LLC | $427.68 | 2022-2025 | |
| Acumed LLC | $385.82 | 2024-2025 | Osteomed |
| Aroa Biosurgery Incorporated | $180.67 | 2024 | |
| Salvin Dental Specialties, INC. | $173.09 | 2021 | |
| Kls-Martin L.P. | $172.74 | 2020 | |
| Keystone Dental INC. | $150.99 | 2025 | |
| Nobel Biocare USA | $41.28 | 2022 | |
| Dentsply Sirona INC | $38.76 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $37.01 | 2020-2025 | Omnimax, Traumaone |
| Pacira Pharmaceuticals Incorporated | $27.45 | 2025 | Iovera |
| Biohorizons Implant Systems INC. | $17.26 | 2025 | Biohorizons Dental Implants |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Arango listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.